Related Experiment Video
Updated: May 24, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Human pancreatic polypeptide in a phospholipid-based micellar formulation.
Amrita Banerjee1, Hayat Onyuksel
1Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Pancreatic polypeptide (PP) formulated in sterically stabilized micelles (SSM) overcomes its short half-life and aggregation issues. This stabilized PP formulation shows improved stability and retains bioactivity, offering a promising therapeutic for diabetes.
Area of Science:
- Biochemistry
- Nanomedicine
- Pharmacology
Background:
- Pancreatic polypeptide (PP) possesses crucial glucoregulatory functions, making it a potential therapeutic agent for diabetes and obesity.
- Therapeutic application of PP is hindered by its short plasma half-life and tendency to aggregate in aqueous solutions.
- Sterically stabilized micelles (SSM) offer a potential solution for stabilizing peptides and improving their delivery.
Purpose of the Study:
- To develop and characterize a formulation of pancreatic polypeptide (PP) encapsulated in sterically stabilized micelles (SSM).
- To enhance the stability and therapeutic applicability of PP by protecting it from degradation and aggregation.
- To evaluate the feasibility of long-term storage and in vitro bioactivity of the PP-SSM formulation.
Main Methods:
- PP was incubated with SSM dispersion in phosphate buffers with or without sodium chloride.
- Dynamic light scattering, fluorescence spectroscopy, and circular dichroism were used to characterize peptide-micelle association and formulation stability.
- High-performance liquid chromatography (HPLC) assessed proteolytic degradation, and in vitro cAMP inhibition studies evaluated bioactivity.
Main Results:
- PP demonstrated self-association with SSM, with interaction influenced by sodium chloride presence.
- The PP-SSM formulation was successfully lyophilized, indicating suitability for long-term storage.
- The formulation significantly improved PP's stability against proteolytic degradation while preserving its in vitro bioactivity.
Conclusions:
- Self-association of PP with phospholipid micelles effectively addresses previous delivery challenges.
- The developed nanomedicine formulation shows promise for the treatment of diabetes.
- Further development of this PP-SSM nanomedicine is warranted for clinical applications.
Related Concept Videos
Production of Pharmaceuticals
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
